Alpha DNA Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,618
Closed -$465K 196
2024
Q3
$465K Buy
+6,618
New +$465K 0.17% 131